https://corcept.com/wp-content/uploads/COR-logo.svg00imc@healthandcommerce.comhttps://corcept.com/wp-content/uploads/COR-logo.svgimc@healthandcommerce.com2021-07-15 00:00:002024-03-15 21:51:20Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
